Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 277 to 286 of 286 entries
Sorted by: Best Match Show Resources per page
New means, new measures: assessing prescription drug-seeking indicators over 10 years of the opioid epidemic.

Addiction (Abingdon, England)

Perry BL, Odabaş M, Yang KC, Lee B, Kaminski P, Aronson B, Ahn YY, Oser CB, Freeman PR, Talbert JC.
PMID: 34227707
Addiction. 2022 Jan;117(1):195-204. doi: 10.1111/add.15635. Epub 2021 Jul 27.

BACKGROUND AND AIMS: Prescription drug-seeking (PDS) from multiple prescribers is a primary means of obtaining prescription opioids; however, PDS behavior has probably evolved in response to policy shifts, and there is little agreement about how to operationalize it. We...

Cite
Perry BL, Odabaş M, Yang KC, et al. New means, new measures: assessing prescription drug-seeking indicators over 10 years of the opioid epidemic. Addiction. 2021;117(1):195-204doi: 10.1111/add.15635.
Perry, B. L., Odabaş, M., Yang, K. C., Lee, B., Kaminski, P., Aronson, B., Ahn, Y. Y., Oser, C. B., Freeman, P. R., & Talbert, J. C. (2022). New means, new measures: assessing prescription drug-seeking indicators over 10 years of the opioid epidemic. Addiction (Abingdon, England), 117(1), 195-204. https://doi.org/10.1111/add.15635
Perry, Brea L, et al. "New means, new measures: assessing prescription drug-seeking indicators over 10 years of the opioid epidemic." Addiction (Abingdon, England) vol. 117,1 (2022): 195-204. doi: https://doi.org/10.1111/add.15635
Perry BL, Odabaş M, Yang KC, Lee B, Kaminski P, Aronson B, Ahn YY, Oser CB, Freeman PR, Talbert JC. New means, new measures: assessing prescription drug-seeking indicators over 10 years of the opioid epidemic. Addiction. 2022 Jan;117(1):195-204. doi: 10.1111/add.15635. Epub 2021 Jul 27. PMID: 34227707; PMCID: PMC8664959.
Copy Download .nbib Format: NLM
Systems engineering analysis of diagnostic referral closed-loop processes.

BMJ open quality

Nehls N, Yap TS, Salant T, Aronson M, Schiff G, Olbricht S, Reddy S, Sternberg SB, Anderson TS, Phillips RS, Benneyan JC.
PMID: 34844935
BMJ Open Qual. 2021 Nov;10(4). doi: 10.1136/bmjoq-2021-001603.

BACKGROUND: Closing loops to complete diagnostic referrals remains a significant patient safety problem in most health systems, with 65%-73% failure rates and significant delays common despite years of improvement efforts, suggesting new approaches may be useful. Systems engineering (SE)...

Cite
Nehls N, Yap TS, Salant T, et al. Systems engineering analysis of diagnostic referral closed-loop processes. BMJ Open Qual. 2021;10(4)doi: 10.1136/bmjoq-2021-001603.
Nehls, N., Yap, T. S., Salant, T., Aronson, M., Schiff, G., Olbricht, S., Reddy, S., Sternberg, S. B., Anderson, T. S., Phillips, R. S., & Benneyan, J. C. (2021). Systems engineering analysis of diagnostic referral closed-loop processes. BMJ open quality, 10(4), . https://doi.org/10.1136/bmjoq-2021-001603
Nehls, Nicole, et al. "Systems engineering analysis of diagnostic referral closed-loop processes." BMJ open quality vol. 10,4 (2021). doi: https://doi.org/10.1136/bmjoq-2021-001603
Nehls N, Yap TS, Salant T, Aronson M, Schiff G, Olbricht S, Reddy S, Sternberg SB, Anderson TS, Phillips RS, Benneyan JC. Systems engineering analysis of diagnostic referral closed-loop processes. BMJ Open Qual. 2021 Nov;10(4). doi: 10.1136/bmjoq-2021-001603. PMID: 34844935; PMCID: PMC8634018.
Copy Download .nbib Format: NLM
Preventable deaths from SARS-CoV-2 in England and Wales: a systematic case series of coroners' reports during the COVID-19 pandemic.

BMJ evidence-based medicine

Swift B, Heneghan C, Aronson J, Howard D, Richards GC.
PMID: 34933933
BMJ Evid Based Med. 2021 Dec 21; doi: 10.1136/bmjebm-2021-111834. Epub 2021 Dec 21.

OBJECTIVES: To examine coroners' Prevention of Future Deaths (PFDs) reports to identify deaths involving SARS-CoV-2 that coroners deemed preventable.DESIGN: Consecutive case series.SETTING: England and Wales.PARTICIPANTS: Patients reported in 510 PFDs dated between 01 January 2020 and 28 June 2021,...

Cite
Swift B, Heneghan C, Aronson J, et al. Preventable deaths from SARS-CoV-2 in England and Wales: a systematic case series of coroners' reports during the COVID-19 pandemic. BMJ Evid Based Med. 2021;doi: 10.1136/bmjebm-2021-111834.
Swift, B., Heneghan, C., Aronson, J., Howard, D., & Richards, G. C. (2021). Preventable deaths from SARS-CoV-2 in England and Wales: a systematic case series of coroners' reports during the COVID-19 pandemic. BMJ evidence-based medicine, . https://doi.org/10.1136/bmjebm-2021-111834
Swift, Bethan, et al. "Preventable deaths from SARS-CoV-2 in England and Wales: a systematic case series of coroners' reports during the COVID-19 pandemic." BMJ evidence-based medicine vol. (2021). doi: https://doi.org/10.1136/bmjebm-2021-111834
Swift B, Heneghan C, Aronson J, Howard D, Richards GC. Preventable deaths from SARS-CoV-2 in England and Wales: a systematic case series of coroners' reports during the COVID-19 pandemic. BMJ Evid Based Med. 2021 Dec 21; doi: 10.1136/bmjebm-2021-111834. Epub 2021 Dec 21. PMID: 34933933.
Copy Download .nbib Format: NLM
Challenges and practical solutions for managing secondary genomic findings in primary care.

European journal of medical genetics

Sebastian A, Carroll JC, Vanstone M, Clausen M, Kodida R, Reble E, Mighton C, Shickh S, Aronson M, Eisen A, Elser C, Lerner-Ellis J, Kim RH, Bombard Y.
PMID: 34768014
Eur J Med Genet. 2021 Nov 09;65(1):104384. doi: 10.1016/j.ejmg.2021.104384. Epub 2021 Nov 09.

Primary care providers will increasingly be tasked with managing most secondary findings from genomic sequencing, but literature exploring their capacity to manage findings beyond conventional genetic testing is limited. This study aimed to explore primary care providers' challenges and...

Cite
Sebastian A, Carroll JC, Vanstone M, et al. Challenges and practical solutions for managing secondary genomic findings in primary care. Eur J Med Genet. 2021;65(1):104384doi: 10.1016/j.ejmg.2021.104384.
Sebastian, A., Carroll, J. C., Vanstone, M., Clausen, M., Kodida, R., Reble, E., Mighton, C., Shickh, S., Aronson, M., Eisen, A., Elser, C., Lerner-Ellis, J., Kim, R. H., & Bombard, Y. (2021). Challenges and practical solutions for managing secondary genomic findings in primary care. European journal of medical genetics, 65(1), 104384. https://doi.org/10.1016/j.ejmg.2021.104384
Sebastian, Agnes, et al. "Challenges and practical solutions for managing secondary genomic findings in primary care." European journal of medical genetics vol. 65,1 (2021): 104384. doi: https://doi.org/10.1016/j.ejmg.2021.104384
Sebastian A, Carroll JC, Vanstone M, Clausen M, Kodida R, Reble E, Mighton C, Shickh S, Aronson M, Eisen A, Elser C, Lerner-Ellis J, Kim RH, Bombard Y. Challenges and practical solutions for managing secondary genomic findings in primary care. Eur J Med Genet. 2021 Nov 09;65(1):104384. doi: 10.1016/j.ejmg.2021.104384. Epub 2021 Nov 09. PMID: 34768014.
Copy Download .nbib Format: NLM
Glycemic Changes and Weight Loss Precede Pancreatic Ductal Adenocarcinoma by up to 3 Years in a Diverse Population.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Brewer MJ, Doucette JT, Bar-Mashiah A, Glickman JW, Kessel E, Aronson A, Lucas AL.
PMID: 34358720
Clin Gastroenterol Hepatol. 2021 Aug 03; doi: 10.1016/j.cgh.2021.07.046. Epub 2021 Aug 03.

BACKGROUND & AIMS: Elevations in fasting blood glucose are observed prior to the development of pancreatic ductal adenocarcinoma (PDAC). Our aim was to describe glycemic and weight changes that occur prior to PDAC diagnosis in a diverse population.METHODS: We...

Cite
Brewer MJ, Doucette JT, Bar-Mashiah A, et al. Glycemic Changes and Weight Loss Precede Pancreatic Ductal Adenocarcinoma by up to 3 Years in a Diverse Population. Clin Gastroenterol Hepatol. 2021;doi: 10.1016/j.cgh.2021.07.046.
Brewer, M. J., Doucette, J. T., Bar-Mashiah, A., Glickman, J. W., Kessel, E., Aronson, A., & Lucas, A. L. (2021). Glycemic Changes and Weight Loss Precede Pancreatic Ductal Adenocarcinoma by up to 3 Years in a Diverse Population. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, . https://doi.org/10.1016/j.cgh.2021.07.046
Brewer, Marlon J, et al. "Glycemic Changes and Weight Loss Precede Pancreatic Ductal Adenocarcinoma by up to 3 Years in a Diverse Population." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. (2021). doi: https://doi.org/10.1016/j.cgh.2021.07.046
Brewer MJ, Doucette JT, Bar-Mashiah A, Glickman JW, Kessel E, Aronson A, Lucas AL. Glycemic Changes and Weight Loss Precede Pancreatic Ductal Adenocarcinoma by up to 3 Years in a Diverse Population. Clin Gastroenterol Hepatol. 2021 Aug 03; doi: 10.1016/j.cgh.2021.07.046. Epub 2021 Aug 03. PMID: 34358720.
Copy Download .nbib Format: NLM
Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Kim SR, Tone A, Kim R, Cesari M, Clarke B, Hart T, Aronson M, Holter S, Lytwyn A, Maganti M, Oldfield L, Gallinger S, Bernardini MQ, Oza AM, Djordjevic B, Lerner-Ellis J, Van de Laar E, Vicus D, Pugh TJ, Pollett A, Ferguson SE, Eiriksson L.
PMID: 35012974
Int J Gynecol Cancer. 2022 Jan 10; doi: 10.1136/ijgc-2021-003082. Epub 2022 Jan 10.

OBJECTIVES: While ovarian cancer is the third most common Lynch syndrome-associated cancer in women, there is no established screening strategy to identify Lynch syndrome in this population. The objective of this study was to assess whether the 4-item brief...

Cite
Kim SR, Tone A, Kim R, et al. Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers. Int J Gynecol Cancer. 2022;doi: 10.1136/ijgc-2021-003082.
Kim, S. R., Tone, A., Kim, R., Cesari, M., Clarke, B., Hart, T., Aronson, M., Holter, S., Lytwyn, A., Maganti, M., Oldfield, L., Gallinger, S., Bernardini, M. Q., Oza, A. M., Djordjevic, B., Lerner-Ellis, J., Van de Laar, E., Vicus, D., Pugh, T. J., Pollett, A., Ferguson, S. E., & Eiriksson, L. (2022). Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, . https://doi.org/10.1136/ijgc-2021-003082
Kim, Soyoun Rachel, et al. "Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers." International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. (2022). doi: https://doi.org/10.1136/ijgc-2021-003082
Kim SR, Tone A, Kim R, Cesari M, Clarke B, Hart T, Aronson M, Holter S, Lytwyn A, Maganti M, Oldfield L, Gallinger S, Bernardini MQ, Oza AM, Djordjevic B, Lerner-Ellis J, Van de Laar E, Vicus D, Pugh TJ, Pollett A, Ferguson SE, Eiriksson L. Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers. Int J Gynecol Cancer. 2022 Jan 10; doi: 10.1136/ijgc-2021-003082. Epub 2022 Jan 10. PMID: 35012974.
Copy Download .nbib Format: NLM
The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

Patel VN, Pieper JA, Poitrasson-Rivière A, Kopin D, Cascino T, Aaronson K, Murthy VL, Koelling T.
PMID: 34505261
J Nucl Cardiol. 2021 Sep 09; doi: 10.1007/s12350-021-02780-x. Epub 2021 Sep 09.

OBJECTIVES: To assess the prognostic value of positron emission tomography (PET) imaging in patients undergoing evaluation for known or suspected cardiac sarcoidosis (CS) while not on active immunotherapy.BACKGROUND: Previous studies have attempted to identify the value of PET imaging...

Cite
Patel VN, Pieper JA, Poitrasson-Rivière A, et al. The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis. J Nucl Cardiol. 2021;doi: 10.1007/s12350-021-02780-x.
Patel, V. N., Pieper, J. A., Poitrasson-Rivière, A., Kopin, D., Cascino, T., Aaronson, K., Murthy, V. L., & Koelling, T. (2021). The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, . https://doi.org/10.1007/s12350-021-02780-x
Patel, Vaiibhav N, et al. "The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis." Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology vol. (2021). doi: https://doi.org/10.1007/s12350-021-02780-x
Patel VN, Pieper JA, Poitrasson-Rivière A, Kopin D, Cascino T, Aaronson K, Murthy VL, Koelling T. The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis. J Nucl Cardiol. 2021 Sep 09; doi: 10.1007/s12350-021-02780-x. Epub 2021 Sep 09. PMID: 34505261.
Copy Download .nbib Format: NLM
Use of Methylene Blue to Track Extensive Perineural Invasion.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

Aronson A, Maxwell Salmon PJ.
PMID: 34559704
Dermatol Surg. 2021 Oct 01;47(10):1403-1404. doi: 10.1097/DSS.0000000000003191.

No abstract available.

Cite
Aronson A, Maxwell Salmon PJ. Use of Methylene Blue to Track Extensive Perineural Invasion. Dermatol Surg. 2021;47(10):1403-1404doi: 10.1097/DSS.0000000000003191.
Aronson, A., & Maxwell Salmon, P. J. (2021). Use of Methylene Blue to Track Extensive Perineural Invasion. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 47(10), 1403-1404. https://doi.org/10.1097/DSS.0000000000003191
Aronson, Adam, and Maxwell Salmon, Paul Jeremy. "Use of Methylene Blue to Track Extensive Perineural Invasion." Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] vol. 47,10 (2021): 1403-1404. doi: https://doi.org/10.1097/DSS.0000000000003191
Aronson A, Maxwell Salmon PJ. Use of Methylene Blue to Track Extensive Perineural Invasion. Dermatol Surg. 2021 Oct 01;47(10):1403-1404. doi: 10.1097/DSS.0000000000003191. PMID: 34559704.
Copy Download .nbib Format: NLM
DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells.

Cancer discovery

Chung J, Maruvka YE, Sudhaman S, Kelly J, Haradhvala NJ, Bianchi V, Edwards M, Forster VJ, Nunes NM, Galati MA, Komosa M, Deshmukh S, Cabric V, Davidson S, Zatzman M, Light N, Hayes R, Brunga L, Anderson ND, Ho B, Hodel KP, Siddaway R, Morrissy AS, Bowers DC, Larouche V, Bronsema A, Osborn M, Cole KA, Opocher E, Mason G, Thomas GA, George B, Ziegler DS, Lindhorst S, Vanan M, Yalon-Oren M, Reddy AT, Massimino M, Tomboc P, Van Damme A, Lossos A, Durno C, Aronson M, Morgenstern DA, Bouffet E, Huang A, Taylor MD, Villani A, Malkin D, Hawkins CE, Pursell ZF, Shlien A, Kunkel TA, Getz G, Tabori U.
PMID: 33355208
Cancer Discov. 2021 May;11(5):1176-1191. doi: 10.1158/2159-8290.CD-20-0790. Epub 2020 Dec 18.

Although replication repair deficiency, either by mismatch repair deficiency (MMRD) and/or loss of DNA polymerase proofreading, can cause hypermutation in cancer, microsatellite instability (MSI) is considered a hallmark of MMRD alone. By genome-wide analysis of tumors with germline and...

Cite
Chung J, Maruvka YE, Sudhaman S, et al. DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells. Cancer Discov. 2020;11(5):1176-1191doi: 10.1158/2159-8290.CD-20-0790.
Chung, J., Maruvka, Y. E., Sudhaman, S., Kelly, J., Haradhvala, N. J., Bianchi, V., Edwards, M., Forster, V. J., Nunes, N. M., Galati, M. A., Komosa, M., Deshmukh, S., Cabric, V., Davidson, S., Zatzman, M., Light, N., Hayes, R., Brunga, L., Anderson, N. D., Ho, B., Hodel, K. P., Siddaway, R., Morrissy, A. S., Bowers, D. C., Larouche, V., Bronsema, A., Osborn, M., Cole, K. A., Opocher, E., Mason, G., Thomas, G. A., George, B., Ziegler, D. S., Lindhorst, S., Vanan, M., Yalon-Oren, M., Reddy, A. T., Massimino, M., Tomboc, P., Van Damme, A., Lossos, A., Durno, C., Aronson, M., Morgenstern, D. A., Bouffet, E., Huang, A., Taylor, M. D., Villani, A., Malkin, D., Hawkins, C. E., Pursell, Z. F., Shlien, A., Kunkel, T. A., Getz, G., & Tabori, U. (2021). DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells. Cancer discovery, 11(5), 1176-1191. https://doi.org/10.1158/2159-8290.CD-20-0790
Chung, Jiil, et al. "DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells." Cancer discovery vol. 11,5 (2021): 1176-1191. doi: https://doi.org/10.1158/2159-8290.CD-20-0790
Chung J, Maruvka YE, Sudhaman S, Kelly J, Haradhvala NJ, Bianchi V, Edwards M, Forster VJ, Nunes NM, Galati MA, Komosa M, Deshmukh S, Cabric V, Davidson S, Zatzman M, Light N, Hayes R, Brunga L, Anderson ND, Ho B, Hodel KP, Siddaway R, Morrissy AS, Bowers DC, Larouche V, Bronsema A, Osborn M, Cole KA, Opocher E, Mason G, Thomas GA, George B, Ziegler DS, Lindhorst S, Vanan M, Yalon-Oren M, Reddy AT, Massimino M, Tomboc P, Van Damme A, Lossos A, Durno C, Aronson M, Morgenstern DA, Bouffet E, Huang A, Taylor MD, Villani A, Malkin D, Hawkins CE, Pursell ZF, Shlien A, Kunkel TA, Getz G, Tabori U. DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells. Cancer Discov. 2021 May;11(5):1176-1191. doi: 10.1158/2159-8290.CD-20-0790. Epub 2020 Dec 18. PMID: 33355208; PMCID: PMC8223607.
Copy Download .nbib Format: NLM
Stereotype Threat.

Shapiro JR, Aronson J.
UIID-AD: 615
2013;95-117.

No abstract available.

Cite
Shapiro JR, Aronson J. Stereotype Threat. 2013;95-117
Shapiro, J. R., & Aronson, J. (2013). Stereotype Threat. 95-117.
Shapiro, J R, and Aronson, J. "Stereotype Threat." vol. (2013): 95-117.
Shapiro JR, Aronson J. Stereotype Threat. 2013;95-117. UIID-AD: 615.
Copy Download .nbib Format: NLM
Showing 277 to 286 of 286 entries